Here is a 400-word summary of the content:
Piramal Pharma Limited, a global pharmaceutical company, has achieved a significant environmental milestone by converting its coal-fired steam boiler at its Digwal facility to operate on biomass briquettes, a renewable energy source. This move is expected to eliminate approximately 24,000 tons of carbon dioxide equivalent (tCO2e) greenhouse gas (GHG) emissions annually, which accounts for about 17% of the company’s total emissions.
This conversion marks a significant step towards the company’s commitment to reduce Scope 1 and 2 GHG emissions by 42% by 2030. The shift to biomass briquettes is a testament to Piramal’s commitment to sustainability and its goal to reduce its environmental footprint.
Nandini Piramal, Chairperson of Piramal Pharma Limited, said that the transition to biomass briquettes is a “step towards reducing our environmental footprint while driving innovation in sustainable manufacturing.” The company aims to support a more sustainable future for generations to come.
The biomass briquettes used by Piramal Pharma are compacted blocks of biomass materials processed and compressed under high pressure. They are made from agricultural waste and support circular economy principles by recycling organic by-products, reducing waste, and promoting sustainability.
Peter DeYoung, CEO of Piramal Global Pharma, emphasized that the transformation at the Digwal facility underscores the company’s commitment to environmental stewardship and sustainable operational practices. By transitioning to biomass briquettes, Piramal is reducing its GHG emissions and setting new industry standards for responsible pharmaceutical manufacturing.
This initiative demonstrates that pharmaceutical companies can implement effective climate action solutions while maintaining operational excellence. Piramal Pharma Limited is committed to responsible growth through environmentally friendly practices to support a greener future.